Liao et al. reported that the synergistic administration of CP and lenvatinib potently suppressed HCC and counteracted LR by regulating autophagy-associated microRNAs in the exosomes, which is achieved by modulating the expression levels of Beclin-1, LC3-II, and P62 111. Here, BECN1 is linked to hepatocellular carcinoma.